John Celebi
President and CEO at Faeth Therapeutics Inc.
Sits on 1 board. Last updated September 28, 2026
Time on boards
- Boards served
- 1
- Current seats
- 1
- Board service
- 4 years
- Director since
- 2023
4 years of board service in total across 1 board, counting each seat separately. Longest: Faeth Therapeutics Inc., 3 years.
Faeth Therapeutics Inc.
Director · PRESIDENT AND CEO
Chief executive roles
Faeth Therapeutics Inc.
· President and CEO
Dates unknown
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
| Date | Company | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Feb 19, 2025 | Faeth Therapeutics Inc. | Shares withheld for tax | −5,558 | $0.48 | $2,668 |
| Feb 15, 2024 | Faeth Therapeutics Inc. | Shares withheld for tax | −5,891 | $0.79 | $4,654 |
| Sep 11, 2023 | Faeth Therapeutics Inc. | Open-market purchase | +500 | $0.85 | $425 |
| Feb 15, 2023 | Faeth Therapeutics Inc. | Grant or award | +51,893 | — | — |
| Feb 15, 2023 | Faeth Therapeutics Inc. | Shares withheld for tax | −20,492 | $1.50 | $30,738 |
| Feb 15, 2023 | Faeth Therapeutics Inc. | Grant or award | +21,300 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.